In a recent clinical test, the Journal of American Medical Association reported that according to a multicenter panel of researchers, a combination of drug therapy has been found to cure hepatitis C in most of the patients who are diagnosed with both hepatitis C and HIV. This news has brought much relief for a majority of people worldwide, as HIV is already a deadly virus and when combined with Hepatitis C, forms a deadly combination. Hepatitis C has now been considered as one of the leading causes of death among the infected patients of HIV.
Dr. Mark Sulkowski, professor of medicine at Johns Hopkins University School of Medicine, said, “The likelihood that a patient with chronic, long-standing hepatitis C infection would have spontaneous cure is near zero, so if these patients had not been treated, none would have been cured.”
Though Hepatitis C can be cured, yet, there is still no known cure for HIV-AIDS. However, it still proves to be an advancement in the world of medicine. Almost seven million patients of HIV are believed to have been infected with Hepatitis-C over the globe. Earlier, the treatment of Hepatitis C was not easy because of a number of factors. However, the phase III trial depicts that combination of ribavirin and sofosbuvir has eventually filled eventually filled that void.
Furthermore, Food and Drug Administration (FDA) in US has already endorsed the use of sofosbuvir. Another drug, Sovaldi, has also been considered as a remedy for Hepatitis C in HIV infected patients. However, the drug has been strongly criticized for its being expensive, and its affordability has been questioned many a times.
Presently, sofosbuvir seems to be a feasible option and has been found suitable for many people worldwide. A recent report from UNAIDS has suggested that more than half of the HIV infected people living around the world are ignorant of the fact they have been infected with the disease, which is the major cause of death, as the disease hasn’t been diagnosed early.